Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




A Simpler Way to Cure Atrial Fibrillation

By HospiMedica staff writers
Posted on 05 Mar 2007
A new study reports the results of an effective new option for treating atrial fibrillation (AF), a common irregular heart rhythm that can cause stroke. More...


Cardiac surgeons at Washington University School of Medicine (St. Louis, MO, USA) have reported further results of the Cox-maze IV clinical study, a simplified cardiac ablation procedure the surgeons believe can replace the older cut and sew Cox-maze III, in which 10 precisely placed incisions in the heart muscle created a maze to redirect errant electrical impulses.

Cox-maze IV is performed with a clamp-like instrument that ablates heart tissue by using radiofrequency energy. By holding areas of the heart within the jaws of the device, surgeons can create lines of ablation, or scar tissue, on the heart muscle. The ablation lines redirect the abnormal electrical currents responsible for atrial fibrillation. In the older Cox-maze III procedure, the lines of ablation were made by cutting the heart muscle, sewing the incisions back together, and letting a scar form. The researchers found that Cox-maze IV was just as effective as Cox-maze III, yet takes one-third the time to perform. The findings were reported in the February 2007 issue of the Journal of Thoracic and Cardiovascular Surgery.

"This is the first documentation of the effectiveness of the ablation devices compared to the incisions of the Cox-maze III,” said Prof. Ralph Damiano Jr., M.D., chief of cardiac surgery at the School of Medicine, and a cardiac surgeon at Barnes-Jewish Hospital (St. Louis, MO, USA). "Instead of reserving the Cox-maze procedure for a select group of patients, we would urge use of this device for virtually all patients who have atrial fibrillation and are scheduled for other cardiac surgery.”

AF can cause fatigue, shortness of breath, exercise intolerance, and palpitations. Patients with the disorder are five times more likely to suffer from stroke and have up to a two-fold higher risk of death. For some patients, medications can control the abnormal heart rhythms and the risk of clotting associated with AF, but unlike the Cox-maze procedure, the drugs do not cure the disorder.


Related Links:
Washington University School of Medicine

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Electrode Solution and Skin Prep
Signaspray
Autoclave
Advance
Critical Care Conversion Kit
Adapter+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.